Estrogen receptor alpha as a target for indole-3-carbinol
Thomas T Y Wang1, Matthew J Milner, John A Milner
1Phytonutrients Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, Beltsville, MD 20705, USA. wangt@ba.ars.usda.gov
Abstract:
A wealth of preclinical evidence supports the antitumorigenic properties of indole-3-carbinol (I3C), which is a major bioactive food component in cruciferous vegetables. However, the underlying molecular mechanism(s) accounting for these effects remain unresolved. In the present study, estrogen receptor alpha (ER-alpha) was identified as a potential molecular target for I3C. Treating MCF-7 cells with 100 microM I3C reduced ER-alpha mRNA expression by approximately 60% compared to controls. This reduction in ER-alpha transcript levels was confirmed using real-time polymerase chain reaction. The I3C dimer, 3,3'-diindolylmethane (DIM), was considerably more effective in depressing ER-alpha mRNA in MCF-7 cells than the monomeric unit. The suppressive effects of 5 microM DIM on ER-alpha mRNA was comparable to that caused by 100 microM I3C. DIM is known to accumulate in the nucleus and is a preferred ligand for aryl hydrocarbon receptor (AhR) to I3C. The addition of other AhR ligands, alpha-naphthoflavone (alpha-NF, 10 microM) and luteolin (10 microM), to the culture media resulted in a similar suppression in ER-alpha mRNA levels to that caused by 5 microM DIM. Thus, it is likely that the binding of ligands to AhR inhibits nuclear ER-alpha transcript. The results from these experiments suggest that the antitumorigenic effects of I3C in MCF-7 human breast cancer cells may arise from its ability to reduce ER-alpha expression through the binding of its metabolite, DIM, to the nuclear AhR.
Insights
Indole-3-carbinol (I3C) may fight cancer by reducing estrogen receptor alpha (ER-alpha) via its metabolite, 3,3'-diindolylmethane (DIM), which binds to the aryl hydrocarbon receptor (AhR). This mechanism was observed in MCF-7 breast cancer cells.
Area of Science:
- Molecular Biology
- Cancer Research
- Nutritional Science
Background:
- Preclinical studies suggest indole-3-carbinol (I3C) has antitumorigenic properties.
- The precise molecular mechanisms behind I3C's effects are not fully understood.
- Estrogen receptor alpha (ER-alpha) is a key factor in many breast cancers.
Purpose of the Study:
- To investigate the molecular targets of indole-3-carbinol (I3C) in cancer cells.
- To elucidate the mechanism by which I3C exerts its antitumorigenic effects.
- To determine the role of estrogen receptor alpha (ER-alpha) in I3C's action.
Main Methods:
- MCF-7 human breast cancer cells were treated with I3C and its metabolite 3,3 -diindolylmethane (DIM).
- Estrogen receptor alpha (ER-alpha) mRNA expression was quantified using real-time polymerase chain reaction.
- The effects of other aryl hydrocarbon receptor (AhR) ligands were assessed.
Main Results:
- Indole-3-carbinol (I3C) significantly reduced ER-alpha mRNA levels in MCF-7 cells.
- The I3C metabolite, 3,3 -diindolylmethane (DIM), was more potent than I3C in suppressing ER-alpha mRNA.
- Aryl hydrocarbon receptor (AhR) ligands, including DIM, inhibited nuclear ER-alpha transcript, suggesting AhR involvement.
Conclusions:
- The antitumorigenic effects of I3C in MCF-7 cells may be mediated by the reduction of ER-alpha expression.
- This reduction is likely achieved through the binding of DIM, an I3C metabolite, to the nuclear aryl hydrocarbon receptor (AhR).
- Targeting ER-alpha via AhR activation presents a potential therapeutic strategy for breast cancer.
Related Concept Videos
Carboxylic Acids to Methylesters: Alkylation using Diazomethane
Synthesis of α-Substituted Carbonyl Compounds: The Stork Enamine Reaction
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
α-Alkylation of Ketones via Enolate Ions
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Reactivity of Enols


